Camp4 Therapeutics: Partnership Holds Just Under 10% Stake in Latest SEC Filing
Camp4 Therapeutics’ latest 13G filing shows a partnership holding nearly 10% of shares—no control change, but a key ownership insight amid volatile stock moves.
2 minutes to read
